An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms

Holly M. Koncicki; Frank Brennan; Katie Vinen; Sara N. Davison

doi:10.1111/sdi.12372

An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms

Holly M. Koncicki, Frank Brennan, Katie Vinen, Sara N. Davison

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The prevalence and severity of symptoms in patients with advanced chronic kidney disease is higher than those of the general population and comparable to those with other chronic and serious medical conditions. Despite the prevalence and severity in this population, symptoms continue to be under-recognized and inadequately managed. The recognition of specific intradialytic pain syndromes such as pain related to arteriovenous access, headaches, muscle cramps or generalized pain by providers may aid in improving patient compliance and quality of life. The approach to pain management in end stage renal disease patients follows that of the general population with specific considerations regarding clearance and potential side effects guiding selection of agents. Overall, evidence is limited regarding the pharmacology of many medications in this population.

Original language	English
Pages (from-to)	384-391
Number of pages	8
Journal	Seminars in Dialysis
Volume	28
Issue number	4
DOIs	https://doi.org/10.1111/sdi.12372
State	Published - 1 Jul 2015
Externally published	Yes

Access to Document

10.1111/sdi.12372

Cite this

@article{89d9580bca7c4ccbb7c046067e041e07,

title = "An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms",

abstract = "The prevalence and severity of symptoms in patients with advanced chronic kidney disease is higher than those of the general population and comparable to those with other chronic and serious medical conditions. Despite the prevalence and severity in this population, symptoms continue to be under-recognized and inadequately managed. The recognition of specific intradialytic pain syndromes such as pain related to arteriovenous access, headaches, muscle cramps or generalized pain by providers may aid in improving patient compliance and quality of life. The approach to pain management in end stage renal disease patients follows that of the general population with specific considerations regarding clearance and potential side effects guiding selection of agents. Overall, evidence is limited regarding the pharmacology of many medications in this population.",

author = "Koncicki, {Holly M.} and Frank Brennan and Katie Vinen and Davison, {Sara N.}",

note = "Publisher Copyright: {\textcopyright} 2015 Wiley Periodicals, Inc.",

year = "2015",

month = jul,

day = "1",

doi = "10.1111/sdi.12372",

language = "English",

volume = "28",

pages = "384--391",

journal = "Seminars in Dialysis",

issn = "0894-0959",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - An Approach to Pain Management in End Stage Renal Disease

T2 - Considerations for General Management and Intradialytic Symptoms

AU - Koncicki, Holly M.

AU - Brennan, Frank

AU - Vinen, Katie

AU - Davison, Sara N.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The prevalence and severity of symptoms in patients with advanced chronic kidney disease is higher than those of the general population and comparable to those with other chronic and serious medical conditions. Despite the prevalence and severity in this population, symptoms continue to be under-recognized and inadequately managed. The recognition of specific intradialytic pain syndromes such as pain related to arteriovenous access, headaches, muscle cramps or generalized pain by providers may aid in improving patient compliance and quality of life. The approach to pain management in end stage renal disease patients follows that of the general population with specific considerations regarding clearance and potential side effects guiding selection of agents. Overall, evidence is limited regarding the pharmacology of many medications in this population.

AB - The prevalence and severity of symptoms in patients with advanced chronic kidney disease is higher than those of the general population and comparable to those with other chronic and serious medical conditions. Despite the prevalence and severity in this population, symptoms continue to be under-recognized and inadequately managed. The recognition of specific intradialytic pain syndromes such as pain related to arteriovenous access, headaches, muscle cramps or generalized pain by providers may aid in improving patient compliance and quality of life. The approach to pain management in end stage renal disease patients follows that of the general population with specific considerations regarding clearance and potential side effects guiding selection of agents. Overall, evidence is limited regarding the pharmacology of many medications in this population.

UR - http://www.scopus.com/inward/record.url?scp=84935752712&partnerID=8YFLogxK

U2 - 10.1111/sdi.12372

DO - 10.1111/sdi.12372

M3 - Article

C2 - 25864854

AN - SCOPUS:84935752712

SN - 0894-0959

VL - 28

SP - 384

EP - 391

JO - Seminars in Dialysis

JF - Seminars in Dialysis

IS - 4

ER -

An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms

Abstract

Access to Document

Fingerprint

Cite this